The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan

Heart failure (HF) is one of the leading causes of morbidity, mortality, and health care expenditures in the US and worldwide. For three decades, the pillars of treatment of HF with reduced ejection fraction (HFrEF) were medications that targeted the sympathetic nervous system (SNS) and the renin-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yandrapalli, Srikanth, Aronow, Wilbert S., Mondal, Pratik, Chabbott, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
State of the Art Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575222/
https://www.ncbi.nlm.nih.gov/pubmed/28883863
http://dx.doi.org/10.5114/aoms.2017.68813

Ejemplares similares

Ejemplares similares